Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery

References

• Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688–701.
   PubMed Web of Science ®Google Scholar
• Muhamad II, Selvakumaran S, Lazim NAM. Designing polymeric nanoparticles for targeted drug delivery system. In: Seifalian A, Mel A, Kalaskar DM, ed. Nanomedicine. Manchester, UK: One Central Press; 2014:287–312. Available from: http://www.onecentralpress.com/nanomedicine, [last accessed 12 Apr 2016].
   Google Scholar
• Zhang L, Zhang L. Lipid polymer hybrid nanoparticles: synthesis, characterization and applications. Nano LIFE 2010;1:163–73.
   Google Scholar
• Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005;19:117–25.
   PubMed Web of Science ®Google Scholar
• Alshamsan A. Nanoprecipitation is more efficient than emulsion solvent evaporation method to encapsulate cucurbitacin I in PLGA nanoparticles. Saudi Pharm J 2014;22:219–22.
   PubMed Web of Science ®Google Scholar
• Severino P, Santana MHA, Souto EB. Optimizing SLN and NLC by 22 full factorial design: effect of homogenization technique. Mater Sci Eng C 2012;32:1375–9.
   PubMed Web of Science ®Google Scholar
• Guhagarkar SA, Gaikwad RV, Samad A, et al. Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. Int J Pharm 2010;401:113–22.
   PubMed Web of Science ®Google Scholar
• Date PV, Samad A, Devarajan PV. Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech 2010;11:304–13.
   PubMed Web of Science ®Google Scholar
• Makwana V, Jain R, Patel K, et al. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm 2015;495:439–46.
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen M, Yang M, et al. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection. Int J Nanomedicine 2014;9:327–36.
   PubMed Web of Science ®Google Scholar
• Fernandes CB, Mandawgade S, Patravale VB. Solid lipid nanoparticles of etoposide using solvent emulsification diffusion technique for parenteral administration. Int J Pharm Biosci Technol 2013;1:27–33.
   Google Scholar
• Nimbalkar UA, Dhoka MV, Sonawane PA. Solid lipid nanoparticles for enhancement of oral bioavailability of cefpodoxime proxetil. Int J Pharm Sci Res 2011;2:2974–82.
   Google Scholar
• Benival DM, Devarajan PV. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. Int J Pharm 2012;423:554–61.
   PubMed Web of Science ®Google Scholar
• Yasir M, Sara UVS. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B 2014;4:454–63.
   PubMed Web of Science ®Google Scholar
• Xue M, Yang M, Zhang W, et al. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. Int J Nanomedicine 2013;8:4677–87.
   PubMed Web of Science ®Google Scholar
• Dang H, Meng MHW, Zhao H, et al. Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies. J Nanopart Res 2014;16:2347.
   Web of Science ®Google Scholar
• Ibrahim WM, AlOmrani AH, Yassin AE. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int J Nanomedicine 2013;9:129–44.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang J, Liu X, et al. Validated LC-MS/MS method for the determination of rosuvastatin in human plasma: application to a bioequivalence study in Chinese volunteers. Pharmacol Pharm 2011;2:341–6.
   Google Scholar
• Shattat G, Al-Qirim R, Al-Hiari Y, et al. Synthesis and anti-hyperlipidemic evaluation of N-(Benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide derivatives in triton WR-1339-induced hyperlipidemic rats. Molecules 2010;15:5840–9.
   PubMed Web of Science ®Google Scholar
• Glantz SA. Primer of biostatistics. 5th edn. New York: McGraw-Hill Inc; 2002.
   Google Scholar
• Ravi PR, Aditya N, Kathuria H, et al. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm 2014;87:114–24.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 2012;64:557–70.
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Porter CJH. Targeting the lymphatics using dendritic polymers (dendrimers). Adv Drug Deliv Rev 2011;63:890–900.
   PubMed Web of Science ®Google Scholar
• Rao DA, Forrest ML, Alani AW, et al. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. J Pharm Sci 2010;99:2018–31.
   PubMed Web of Science ®Google Scholar
• Khan AA, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 2013;8:2733–44.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Roy T. Nanoparticulate drug-delivery systems: lymphatic uptake and its gastrointestinal applications. J Appl Pharm Sci 2014;4:123–30.
   Google Scholar
• Lee MK, Kim MY, Kim S, Lee J. Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate. J Pharm Sci 2009;98:4808–17.
   PubMed Web of Science ®Google Scholar
• Wizel S, Niddam Hildesheim V, Shabat S. 2008. Crystalline rosuvastatin calcium. US2008/0176878 A1.
   Google Scholar
• Torrado S, Torrado S. Characterization of physical state of mannitol after freeze-drying: effect of acetylsalicylic acid as a second crystalline cosolute. Chem Pharm Bull 2002;50:567–70.
   PubMed Web of Science ®Google Scholar
• Salih OS, Samein LH, Ali WK. Formulation and in vitro evaluation of rosuvastatin calcium niosomes. Int J Pharm Pharm Sci 2013;5:525–35.
   Google Scholar
• Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010;7:479–95.
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Lee S, Bhushan B. A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng 2005;33:179–90.
   PubMed Web of Science ®Google Scholar
• Beg S, Raza K, Kumar R, et al. Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium. RSC Adv 2016;6:8173–87.
   Web of Science ®Google Scholar
• Inami M, Kawamura I, Tsujimoto S, et al. FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391. J Antibiot 2005;58:640–7.
   PubMed Web of Science ®Google Scholar